Stock Analysts’ Price Target Changes for June 30th (ACAD, ACB, ASTL, CE, CNXC, COUR, DHT.UN, HOOD, HPS.A, HRL)

Stock Analysts’ price target changes for Tuesday, June 30th:

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its target price boosted by Bank of America Corporation from $29.00 to $30.00. The firm currently has a buy rating on the stock.

Aurora Cannabis (TSE:ACB) had its target price trimmed by Canaccord Genuity Group Inc. from C$6.50 to C$5.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.

Algoma Steel Group (TSE:ASTL) was given a C$7.00 target price by analysts at Royal Bank Of Canada. The firm currently has a sector perform rating on the stock.

Celanese (NYSE:CE) had its price target reduced by Bank of America Corporation from $72.00 to $63.00. They currently have a buy rating on the stock.

Concentrix (NASDAQ:CNXC) had its price target reduced by Bank of America Corporation from $32.00 to $26.00. Bank of America Corporation currently has a neutral rating on the stock.

Coursera (NYSE:COUR) had its price target trimmed by Bank of America Corporation from $8.00 to $7.00. They currently have a neutral rating on the stock.

DRI Healthcare Trust (TSE:DHT.UN) had its target price increased by Stifel Nicolaus from C$23.00 to C$24.00. The firm currently has a buy rating on the stock.

DRI Healthcare Trust (TSE:DHT.UN) had its target price raised by Canaccord Genuity Group Inc. from C$22.25 to C$23.00. The firm currently has a buy rating on the stock.

Robinhood Markets (NASDAQ:HOOD) had its target price raised by Deutsche Bank Aktiengesellschaft from $105.00 to $113.00. The firm currently has a buy rating on the stock.

Hammond Power Solutions (TSE:HPS.A) was given a C$405.00 target price by analysts at Raymond James Financial, Inc.. The firm currently has an outperform rating on the stock.

Hammond Power Solutions (TSE:HPS.A) had its price target increased by Acumen Capital from C$345.00 to C$365.00. They currently have a buy rating on the stock.

Hormel Foods (NYSE:HRL) had its target price boosted by Bank of America Corporation from $25.00 to $27.00. They currently have a neutral rating on the stock.

Huntsman (NYSE:HUN) had its target price increased by Bank of America Corporation from $10.00 to $11.00. Bank of America Corporation currently has an underperform rating on the stock.

Koryx Copper (CVE:KRY) was given a C$6.00 target price by analysts at BMO Capital Markets. The firm currently has an outperform rating on the stock.

Merck & Co., Inc. (NYSE:MRK) had its price target raised by Bank of America Corporation from $130.00 to $141.00. Bank of America Corporation currently has a buy rating on the stock.

Metro (TSE:MRU) was given a C$105.00 price target by analysts at National Bank Financial. The firm currently has a sector perform rating on the stock.

Mullen Group (TSE:MTL) had its target price raised by Canadian Imperial Bank of Commerce from C$20.00 to C$22.00. They currently have a neutral rating on the stock.

Neo Performance Materials (TSE:NEO) had its price target increased by ATB Cormark Capital Markets from C$37.50 to C$43.00. ATB Cormark Capital Markets currently has an outperform rating on the stock.

Perfect Moment (NASDAQ:PMNT) had its price target cut by Maxim Group from $1.50 to $0.40. The firm currently has a buy rating on the stock.

Russel Metals (TSE:RUS) had its price target boosted by Royal Bank Of Canada from C$63.00 to C$68.00. They currently have an outperform rating on the stock.

Ultrapar Participacoes (NYSE:UGP) had its target price boosted by Bank of America Corporation from $6.30 to $6.80. The firm currently has a neutral rating on the stock.

Unicycive Therapeutics (NASDAQ:UNCY) had its target price trimmed by HC Wainwright from $22.00 to $15.00. They currently have a buy rating on the stock.

Westlake (NYSE:WLK) had its target price trimmed by Bank of America Corporation from $104.00 to $85.00. They currently have a neutral rating on the stock.

Receive News & Ratings for ACADIA Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ACADIA Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.